Chronic kidney disease (CKD) affects 11% of the population in Switzerland & US per year and is a major public health issue. Also, the CKD is 16th most prominent reason of life lost worldwide. MRI T1-mapping is a non-invasive way to monitor the renal prognosis. Recent studies show that the ∆T1 (cortex-medullary difference) has a strong positive correlation with fibrosis in CKD patients and is an important biomarker for CKD. This work proposes a validation of the T1-map cortico-medullary difference (ΔT1) values measured from automatically segmented cortex and medulla for eGFR and fibrosis assessment of allograft kidneys.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords